Vext Science, Inc. ( VEXTF) - Key Metrics
VEXTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.05 | $0 | $0 | $0 |
| 2026Q1 | $0.05 | $0 | $0.01 | $0 |
| 2025Q4 | $0.08 | -$0.06 | $0.02 | $0.01 |
| 2025Q3 | $0.05 | -$0.01 | $0.01 | $0 |
| 2025Q2 | $0.05 | -$0.01 | $0.02 | $0.01 |
VEXTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -30.08 |
| 2026Q1 | 0% | -12.68 |
| 2025Q4 | 0% | -0.82 |
| 2025Q3 | 0% | -6.19 |
| 2025Q2 | 0% | -5.23 |
VEXTF
Price: $0.16
52 week price:
Earnings Per Share: -0.07 USD
P/E Ratio: -2.57
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 37.7 million